These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2843841)

  • 1. Prognostic significance of immunohistochemical parameters in breast carcinomas.
    Wrba F; Reiner A; Markis-Ritzinger E; Holzner JH; Reiner G; Spona J
    Pathol Res Pract; 1988 Jun; 183(3):277-83. PubMed ID: 2843841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value and prognostic significance of alpha-lactalbumin (ALA), lactoferrin (Lfr) and HMFG-2 in primary breast cancers. An immunohistochemical study].
    Wrba F; Ritzinger E; Reiner A; Holzner JH
    Pathologe; 1987 Jan; 8(1):25-30. PubMed ID: 3031642
    [No Abstract]   [Full Text] [Related]  

  • 3. Human milk fat globule antigen III D 5, steroid receptors and histopathologic parameters in breast cancer.
    Helle M; Helin H; Antonen J; Krohn K
    APMIS; 1988 May; 96(5):415-20. PubMed ID: 2837254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study.
    Wrba F; Reiner A; Ritzinger E; Holzner JH; Reiner G
    Pathol Res Pract; 1988 Feb; 183(1):25-9. PubMed ID: 3362749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural and immunohistochemical characteristics of lipid-rich carcinoma of the breast.
    Wrba F; Ellinger A; Reiner G; Spona J; Holzner JH
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):381-5. PubMed ID: 2845641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study.
    Wrba F; Ritzinger E; Reiner A; Holzner JH
    Virchows Arch A Pathol Anat Histopathol; 1986; 410(1):69-73. PubMed ID: 3024390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study.
    Wrba F; Chott A; Reiner A; Reiner G; Markis-Ritzinger E; Holzner JH
    Oncology; 1989; 46(4):255-9. PubMed ID: 2662089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of estrogen receptor protein and histopathologic characteristics in 175 cases of breast carcinoma.
    Ahluwali CK; Verma U; Sundaram KR; Verma K
    Indian J Pathol Microbiol; 1987 Jul; 30(3):299-305. PubMed ID: 2835317
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS; Kim JE; Kim YA; Kim YC; Kim SW
    Histopathology; 2005 Dec; 47(6):625-30. PubMed ID: 16324201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
    Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The demonstration of alpha lactalbumin in human breast carcinomas.
    Walker RA
    J Pathol; 1979 Sep; 129(1):37-42. PubMed ID: 230330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
    Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
    Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
    Mauriac L; Wafflart J; Trojani M; Durand M
    Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.